Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1121-1130 of 2916 for cancer

Edit search filters
  1. CC-220-MM-001: A Phase 1b/2a Multicenter, Open-Label, Dose-Escalation Study To Determine The Maximum Tolerated Dose, Assess The Safety, Tolerability, Pharmacokinetics And Efficacy Of CC-220 As Monotherapy And In Combination With Other Treatments In Subjects With Multiple Myeloma

    Scottsdale/Phoenix, AZ

  2. Study Of ADI-PEG 20 Or Placebo Plus Gem And Doc In Previously Treated Subjects With Leiomyosarcoma (ARGSARC)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Study Of Intralesional Cemiplimab In Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

    Scottsdale/Phoenix, AZ

  4. A Study To Evaluate TAK-981 Given With Monoclonal Antibodies In Adults With Relapsed Or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Study Of MRI-Targeted Biopsy Compared To Standard Ultrasound Guided Biopsy For The Diagnosis Of Prostate Cancer

    Rochester, MN

  6. Hypo-fractionated Radiation Therapy With Or Without Androgen Suppression For Intermediate Risk Prostate Cancer

    Scottsdale/Phoenix, AZ

  7. Ramucirumab And Paclitaxel Or FOLFIRI In Advanced Small Bowel Cancers

    Rochester, MN

  8. Study Of TBio-6517, Given Intratumorally, Alone Or In Combination With Pembrolizumab, In Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Early Identification Of Chemotherapy Induced Cardiac Toxicity

    Rochester, MN

  10. NKX101, Intravenous Allogeneic CAR NK Cells, In Adults With AML Or MDS

    Jacksonville, FL

.

Mayo Clinic Footer